img

Global Medical Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Medical Biomarkers market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Sepsis Biomarkers accounting for % of the Medical Biomarkers global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Diagnostics segment is altered to an % CAGR throughout this forecast period.
The global key companies of Medical Biomarkers include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott and Agilent Technologies, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States Medical Biomarkers market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Medical Biomarkers landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Medical Biomarkers market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Medical Biomarkers market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Medical Biomarkers market. Readers of the report can become informed about current and future trends of the global Medical Biomarkers market and how they will impact market growth during the forecast period.



By Company


Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other

Segment by Application


Diagnostics
Drug Discovery
Personalized Medicine
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Medical Biomarkers in global and regional level.
Chapter 3Detailed analysis of Medical Biomarkers companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Biomarkers revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Biomarkers Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Medical Biomarkers Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Medical Biomarkers Market Size (2018-2034)
2.2 Medical Biomarkers Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Medical Biomarkers Market Size by Region (2018-2023)
2.4 Global Medical Biomarkers Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Medical Biomarkers Countries Ranking by Market Size
3 Medical Biomarkers Competitive by Company
3.1 Global Medical Biomarkers Revenue by Players
3.1.1 Global Medical Biomarkers Revenue by Players (2018-2023)
3.1.2 Global Medical Biomarkers Market Share by Players (2018-2023)
3.2 Global Medical Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Medical Biomarkers Revenue
3.4 Global Medical Biomarkers Market Concentration Ratio
3.4.1 Global Medical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Biomarkers Revenue in 2024
3.5 Global Key Players of Medical Biomarkers Head office and Area Served
3.6 Global Key Players of Medical Biomarkers, Product and Application
3.7 Global Key Players of Medical Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Medical Biomarkers Breakdown Data by Type
4.1 Global Medical Biomarkers Historic Revenue by Type (2018-2023)
4.2 Global Medical Biomarkers Forecasted Revenue by Type (2024-2034)
5 Global Medical Biomarkers Breakdown Data by Application
5.1 Global Medical Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Medical Biomarkers Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Medical Biomarkers Revenue by Company (2021-2023)
6.2 North America Medical Biomarkers Revenue by Type (2018-2034)
6.3 North America Medical Biomarkers Revenue by Application (2018-2034)
6.4 North America Medical Biomarkers Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Medical Biomarkers Revenue by Company (2021-2023)
7.2 Europe Medical Biomarkers Revenue by Type (2018-2034)
7.3 Europe Medical Biomarkers Revenue by Application (2018-2034)
7.4 Europe Medical Biomarkers Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Medical Biomarkers Revenue by Company (2021-2023)
8.2 Asia Pacific Medical Biomarkers Revenue by Type (2018-2034)
8.3 Asia Pacific Medical Biomarkers Revenue by Application (2018-2034)
8.4 Asia Pacific Medical Biomarkers Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Medical Biomarkers Revenue by Company (2021-2023)
9.2 Latin America Medical Biomarkers Revenue by Type (2018-2034)
9.3 Latin America Medical Biomarkers Revenue by Application (2018-2034)
9.4 Latin America Medical Biomarkers Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Medical Biomarkers Revenue by Company (2021-2023)
10.2 Middle East and Africa Medical Biomarkers Revenue by Type (2018-2034)
10.3 Middle East and Africa Medical Biomarkers Revenue by Application (2018-2034)
10.4 Middle East and Africa Medical Biomarkers Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Medical Biomarkers Products and Services
11.1.4 Thermo Fisher Scientific Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.1.5 Thermo Fisher Scientific Medical Biomarkers SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Medical Biomarkers Products and Services
11.2.4 Merck Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.2.5 Merck Medical Biomarkers SWOT Analysis
11.2.6 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Medical Biomarkers Products and Services
11.3.4 Bio-Rad Laboratories Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.3.5 Bio-Rad Laboratories Medical Biomarkers SWOT Analysis
11.3.6 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Medical Biomarkers Products and Services
11.4.4 QIAGEN Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.4.5 QIAGEN Medical Biomarkers SWOT Analysis
11.4.6 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Medical Biomarkers Products and Services
11.5.4 Roche Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.5.5 Roche Medical Biomarkers SWOT Analysis
11.5.6 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Medical Biomarkers Products and Services
11.6.4 Danaher Corporation Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.6.5 Danaher Corporation Medical Biomarkers SWOT Analysis
11.6.6 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Medical Biomarkers Products and Services
11.7.4 Siemens Healthcare Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.7.5 Siemens Healthcare Medical Biomarkers SWOT Analysis
11.7.6 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Medical Biomarkers Products and Services
11.8.4 Abbott Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.8.5 Abbott Medical Biomarkers SWOT Analysis
11.8.6 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Medical Biomarkers Products and Services
11.9.4 Agilent Technologies Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023)
11.9.5 Agilent Technologies Medical Biomarkers SWOT Analysis
11.9.6 Agilent Technologies Recent Development
12 Medical Biomarkers Market Dynamics
12.1 Medical Biomarkers Industry Trends
12.2 Medical Biomarkers Market Drivers
12.3 Medical Biomarkers Market Challenges
12.4 Medical Biomarkers Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Medical Biomarkers Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Sepsis Biomarkers
Table 3. Key Players of Antibiotic Resistance Biomarkers
Table 4. Key Players of Traumatic Brain Injury (TBI) Testing Biomarkers
Table 5. Key Players of Stroke Testing Biomarkers
Table 6. Key Players of Antibiotic Stewardship Biomarkers
Table 7. Key Players of Other
Table 8. Global Medical Biomarkers Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 9. Global Medical Biomarkers Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 10. Global Medical Biomarkers Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Medical Biomarkers Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 12. Global Medical Biomarkers Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 13. Global Medical Biomarkers Revenue by Players (2018-2023) & (US$ Million)
Table 14. Global Medical Biomarkers Market Share by Players (2018-2023)
Table 15. Global Top Medical Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Biomarkers as of 2024)
Table 16. Ranking of Global Top Medical Biomarkers Companies by Revenue (US$ Million) in 2024
Table 17. Global 5 Largest Players Market Share by Medical Biomarkers Revenue (CR5 and HHI) & (2018-2023)
Table 18. Global Key Players of Medical Biomarkers, Headquarters and Area Served
Table 19. Global Key Players of Medical Biomarkers, Product and Application
Table 20. Global Key Players of Medical Biomarkers, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Medical Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global Medical Biomarkers Revenue Market Share by Type (2018-2023)
Table 24. Global Medical Biomarkers Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 25. Global Medical Biomarkers Revenue Market Share by Type (2024-2034)
Table 26. Global Medical Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global Medical Biomarkers Revenue Market Share by Application (2018-2023)
Table 28. Global Medical Biomarkers Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 29. Global Medical Biomarkers Revenue Market Share by Application (2024-2034)
Table 30. North America Medical Biomarkers Revenue by Company (2021-2023) & (US$ Million)
Table 31. North America Medical Biomarkers Revenue by Type (2018-2023) & (US$ Million)
Table 32. North America Medical Biomarkers Revenue by Type (2024-2034) & (US$ Million)
Table 33. North America Medical Biomarkers Revenue by Application (2018-2023) & (US$ Million)
Table 34. North America Medical Biomarkers Revenue by Application (2024-2034) & (US$ Million)
Table 35. North America Medical Biomarkers Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Medical Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 37. North America Medical Biomarkers Revenue by Country (2024-2034) & (US$ Million)
Table 38. Europe Medical Biomarkers Revenue by Company (2021-2023) & (US$ Million)
Table 39. Europe Medical Biomarkers Revenue by Type (2018-2023) & (US$ Million)
Table 40. Europe Medical Biomarkers Revenue by Type (2024-2034) & (US$ Million)
Table 41. Europe Medical Biomarkers Revenue by Application (2018-2023) & (US$ Million)
Table 42. Europe Medical Biomarkers Revenue by Application (2024-2034) & (US$ Million)
Table 43. Europe Medical Biomarkers Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Europe Medical Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 45. Europe Medical Biomarkers Revenue by Country (2024-2034) & (US$ Million)
Table 46. Asia Pacific Medical Biomarkers Revenue by Company (2021-2023) & (US$ Million)
Table 47. Asia Pacific Medical Biomarkers Revenue by Type (2018-2023) & (US$ Million)
Table 48. Asia Pacific Medical Biomarkers Revenue by Type (2024-2034) & (US$ Million)
Table 49. Asia Pacific Medical Biomarkers Revenue by Application (2018-2023) & (US$ Million)
Table 50. Asia Pacific Medical Biomarkers Revenue by Application (2024-2034) & (US$ Million)
Table 51. Asia-Pacific Medical Biomarkers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 52. Asia Pacific Medical Biomarkers Revenue by Region (2018-2023) & (US$ Million)
Table 53. Asia Pacific Medical Biomarkers Revenue by Region (2024-2034) & (US$ Million)
Table 54. Latin America Medical Biomarkers Revenue by Company (2021-2023) & (US$ Million)
Table 55. Latin America Medical Biomarkers Revenue by Type (2018-2023) & (US$ Million)
Table 56. Latin America Medical Biomarkers Revenue by Type (2024-2034) & (US$ Million)
Table 57. Latin America Medical Biomarkers Revenue by Application (2018-2023) & (US$ Million)
Table 58. Latin America Medical Biomarkers Revenue by Application (2024-2034) & (US$ Million)
Table 59. Latin America Medical Biomarkers Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 60. Latin America Medical Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 61. Latin America Medical Biomarkers Revenue by Country (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Medical Biomarkers Revenue by Company (2021-2023) & (US$ Million)
Table 63. Middle East and Africa Medical Biomarkers Revenue by Type (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Medical Biomarkers Revenue by Type (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Medical Biomarkers Revenue by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Medical Biomarkers Revenue by Application (2024-2034) & (US$ Million)
Table 67. Middle East and Africa Medical Biomarkers Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 68. Middle East and Africa Medical Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 69. Middle East and Africa Medical Biomarkers Revenue by Country (2024-2034) & (US$ Million)
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Medical Biomarkers Product and Services
Table 73. Thermo Fisher Scientific Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 74. Thermo Fisher Scientific Medical Biomarkers SWOT Analysis
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Medical Biomarkers Product and Services
Table 79. Merck Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 80. Merck Medical Biomarkers SWOT Analysis
Table 81. Merck Recent Development
Table 82. Bio-Rad Laboratories Company Details
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories Medical Biomarkers Product and Services
Table 85. Bio-Rad Laboratories Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 86. Bio-Rad Laboratories Medical Biomarkers SWOT Analysis
Table 87. Bio-Rad Laboratories Recent Development
Table 88. QIAGEN Company Details
Table 89. QIAGEN Business Overview
Table 90. QIAGEN Medical Biomarkers Product and Services
Table 91. QIAGEN Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 92. QIAGEN Medical Biomarkers SWOT Analysis
Table 93. QIAGEN Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Medical Biomarkers Product and Services
Table 97. Roche Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 98. Roche Medical Biomarkers SWOT Analysis
Table 99. Roche Recent Development
Table 100. Danaher Corporation Company Details
Table 101. Danaher Corporation Business Overview
Table 102. Danaher Corporation Medical Biomarkers Product and Services
Table 103. Danaher Corporation Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 104. Danaher Corporation Medical Biomarkers SWOT Analysis
Table 105. Danaher Corporation Recent Development
Table 106. Siemens Healthcare Company Details
Table 107. Siemens Healthcare Business Overview
Table 108. Siemens Healthcare Medical Biomarkers Product and Services
Table 109. Siemens Healthcare Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 110. Siemens Healthcare Medical Biomarkers SWOT Analysis
Table 111. Siemens Healthcare Recent Development
Table 112. Abbott Company Details
Table 113. Abbott Business Overview
Table 114. Abbott Medical Biomarkers Product and Services
Table 115. Abbott Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 116. Abbott Medical Biomarkers SWOT Analysis
Table 117. Abbott Recent Development
Table 118. Agilent Technologies Company Details
Table 119. Agilent Technologies Business Overview
Table 120. Agilent Technologies Medical Biomarkers Product and Services
Table 121. Agilent Technologies Medical Biomarkers Revenue in Medical Biomarkers Business (2018-2023) & (US$ Million)
Table 122. Agilent Technologies Medical Biomarkers SWOT Analysis
Table 123. Agilent Technologies Recent Development
Table 124. Medical Biomarkers Market Trends
Table 125. Medical Biomarkers Market Drivers
Table 126. Medical Biomarkers Market Challenges
Table 127. Medical Biomarkers Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Biomarkers Product Picture
Figure 2. Global Medical Biomarkers Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Medical Biomarkers Market Share by Type: 2024 VS 2034
Figure 4. Sepsis Biomarkers Features
Figure 5. Antibiotic Resistance Biomarkers Features
Figure 6. Traumatic Brain Injury (TBI) Testing Biomarkers Features
Figure 7. Stroke Testing Biomarkers Features
Figure 8. Antibiotic Stewardship Biomarkers Features
Figure 9. Other Features
Figure 10. Global Medical Biomarkers Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 11. Global Medical Biomarkers Market Share by Application: 2024 VS 2034
Figure 12. Diagnostics
Figure 13. Drug Discovery
Figure 14. Personalized Medicine
Figure 15. Other
Figure 16. Medical Biomarkers Report Years Considered
Figure 17. Global Medical Biomarkers Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Medical Biomarkers Market Size 2018-2034 (US$ Million)
Figure 19. Global Medical Biomarkers Market Size Market Share by Region: 2024 VS 2034
Figure 20. Global Medical Biomarkers Revenue Market Share by Region in 2018 VS 2024
Figure 21. Global Medical Biomarkers Revenue Market Share Forecast by Region (2024-2034)
Figure 22. Global Top 10 Medical Biomarkers Countries Ranking by Market Size (US$ Million) in 2024
Figure 23. Global Medical Biomarkers Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 24. Global Medical Biomarkers Market Share by Players in 2024
Figure 25. Global Top Medical Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Biomarkers as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Medical Biomarkers Revenue in 2024
Figure 27. North America Medical Biomarkers Revenue Market Share by Company in 2024
Figure 28. North America Medical Biomarkers Revenue Market Share by Type (2018-2034)
Figure 29. North America Medical Biomarkers Revenue Market Share by Application (2018-2034)
Figure 30. North America Medical Biomarkers Revenue Share by Country (2018-2034)
Figure 31. United States Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 32. Canada Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 33. Europe Medical Biomarkers Revenue Market Share by Company in 2024
Figure 34. Europe Medical Biomarkers Revenue Market Share by Type (2018-2034)
Figure 35. Europe Medical Biomarkers Revenue Market Share by Application (2018-2034)
Figure 36. Europe Medical Biomarkers Revenue Share by Country (2018-2034)
Figure 37. Germany Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 38. France Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 39. U.K. Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 40. Italy Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 41. Russia Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 42. Asia Pacific Medical Biomarkers Revenue Market Share by Company in 2024
Figure 43. Asia Pacific Medical Biomarkers Revenue Market Share by Type (2018-2034)
Figure 44. Asia Pacific Medical Biomarkers Revenue Market Share by Application (2018-2034)
Figure 45. Asia Pacific Medical Biomarkers Revenue Share by Region (2018-2034)
Figure 46. China Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 47. Japan Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 48. South Korea Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 49. India Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 50. Australia Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 51. China Taiwan Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 52. Indonesia Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 53. Thailand Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 54. Malaysia Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 55. Latin America Medical Biomarkers Revenue Market Share by Company in 2024
Figure 56. Latin America Medical Biomarkers Revenue Market Share by Type (2018-2034)
Figure 57. Latin America Medical Biomarkers Revenue Market Share by Application (2018-2034)
Figure 58. Latin America Medical Biomarkers Revenue Share by Country (2018-2034)
Figure 59. Mexico Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 60. Brazil Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 61. Argentina Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 62. Middle East and Africa Medical Biomarkers Revenue Market Share by Company in 2024
Figure 63. Middle East and Africa Medical Biomarkers Revenue Market Share by Type (2018-2034)
Figure 64. Middle East and Africa Medical Biomarkers Revenue Market Share by Application (2018-2034)
Figure 65. Middle East and Africa Medical Biomarkers Revenue Share by Country (2018-2034)
Figure 66. Turkey Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 67. Saudi Arabia Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 68. UAE Medical Biomarkers Revenue (2018-2034) & (US$ Million)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 70. Merck Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 72. QIAGEN Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 73. Roche Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 74. Danaher Corporation Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 75. Siemens Healthcare Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 76. Abbott Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 77. Agilent Technologies Revenue Growth Rate in Medical Biomarkers Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed